How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Pages (from-to)80-83
JournalTranslational Pediatrics
Volume2
Issue number2
DOIs
Publication statusPublished - 2013

Cite this

@article{9f7a3a48191647548db73242d4586243,
title = "How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?",
author = "G.J. Schuurhuis and J. Cloos and G.J. Ossenkoppele",
year = "2013",
doi = "10.3978/j.issn.2224-4336.2013.04.09",
language = "Undefined/Unknown",
volume = "2",
pages = "80--83",
journal = "Translational Pediatrics",
issn = "2224-4336",
publisher = "AME Publishing Company",
number = "2",

}

How to assess minimal residual disease in pediatric and adult acute myeloid leukemia? / Schuurhuis, G.J.; Cloos, J.; Ossenkoppele, G.J.

In: Translational Pediatrics, Vol. 2, No. 2, 2013, p. 80-83.

Research output: Contribution to journalArticleAcademic

TY - JOUR

T1 - How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?

AU - Schuurhuis, G.J.

AU - Cloos, J.

AU - Ossenkoppele, G.J.

PY - 2013

Y1 - 2013

U2 - 10.3978/j.issn.2224-4336.2013.04.09

DO - 10.3978/j.issn.2224-4336.2013.04.09

M3 - Article

VL - 2

SP - 80

EP - 83

JO - Translational Pediatrics

JF - Translational Pediatrics

SN - 2224-4336

IS - 2

ER -